Literature DB >> 18816669

Adverse events of IBD therapies.

Maria Lia Scribano1.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18816669     DOI： 10.1002/ibd.20702

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN： 1078-0998            Impact factor:   5.325


× No keyword cloud information.
  6 in total

1.  Clinical presentation and treatment strategies for ulcerative colitis: A retrospective study of 247 inpatients.

Authors:  Yan-Cheng Dai; Ya-Li Zhang; Li-Juan Wang; Qian Guo; Kun Yang; Ren-Hao Ye; Zhi-Peng Tang
Journal:  Chin J Integr Med       Date:  2015-10-26       Impact factor: 1.978

2.  Hyposensitization trial using salazosulfapyridine in a case of mesalamine intolerance.

Authors:  Koichi Soga; Kenji Itani
Journal:  Clin J Gastroenterol       Date:  2019-04-29

3.  Mesalamine-induced myocarditis and coronary vasculitis in a pediatric ulcerative colitis patient: a case report.

Authors:  Elimarys Perez-Colon; Gul H Dadlani; Ivan Wilmot; Michelle Miller
Journal:  Case Rep Pediatr       Date:  2011-12-21

4.  Managing chronic disease in Ireland: hospital admission rates and clinical outcomes in a large ulcerative colitis population.

Authors:  A N Desmond; F Shanahan
Journal:  Ir J Med Sci       Date:  2011-09-24       Impact factor: 2.089

Review 5.  Metallothioneins in Inflammatory Bowel Diseases: Importance in Pathogenesis and Potential Therapy Target.

Authors:  Anna Socha-Banasiak; Patrycja Sputa-Grzegrzółka; Jędrzej Grzegrzółka; Krzysztof Pacześ; Piotr Dzięgiel; Beata Sordyl; Hanna Romanowicz; Elżbieta Czkwianianc
Journal:  Can J Gastroenterol Hepatol       Date:  2021-04-24

6.  Mesalazine-Induced Myopericarditis in a Patient with a Recent Diagnosis of Crohn's Disease: Apropos of a Case.

Authors:  Michele Sorleto; Stefanie Dürrwald; Marcus Wiemer
Journal:  Case Rep Cardiol       Date:  2015-07-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.